# Systemic Effects of Lidocaine Infusion for TAP Block Catheter

> **NCT03971708** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 80 (actual)

## Conditions studied

- Nephrectomy

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT03971708
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03971708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03971708, "Systemic Effects of Lidocaine Infusion for TAP Block Catheter". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03971708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*